Insider · CIK 0001198332

PENHOET EDWARD

Reports to the SEC for 16 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001198332

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,058 sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,281 sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2019-01-03	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2017-01-04	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-01-04	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Director	AAward	+9,300 sh	—	—	9,300
2015-06-04	SCYXSCYNEXIS INC · Stock Option (right to buy)A Award	Director	AAward	+8,800 sh	—	—	8,800
2015-01-07	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-01-07	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Director	AAward	+9,300 sh	—	—	9,300
2014-07-29	IMMUNE DESIGN CORP.C Conversion	Director	CConversion	+734K sh	—	—	733,943
2014-07-29	IMMUNE DESIGN CORP.C Conversion	Director	CConversion	+532K sh	—	—	1,265,786
2014-07-29	IMMUNE DESIGN CORP.C Conversion	Director	CConversion	+612K sh	—	—	1,877,406
2014-07-29	IMMUNE DESIGN CORP.C Conversion	Director	CConversion	+306K sh	—	—	2,183,216
2014-07-29	IMMUNE DESIGN CORP.P Purchase	Director	PPurchase	+300K sh	$12.00	+$3.59M	2,482,775
2014-07-29	IMMUNE DESIGN CORP.Series A Preferred StockC Conversion	Director	CConversion	−734K sh	—	—	0
2014-07-29	IMMUNE DESIGN CORP.Series B Preferred StockC Conversion	Director	CConversion	−532K sh	—	—	0
2014-07-29	IMMUNE DESIGN CORP.Series C Preferred StockC Conversion	Director	CConversion	−612K sh	—	—	0
2014-07-29	IMMUNE DESIGN CORP.Series C Preferred Stock Warrant (right to buy)X Exercise of In-Money	Director	XExercise of In-Money	−306K sh	—	—	0
2014-07-29	IMMUNE DESIGN CORP.Series C Preferred StockX Exercise of In-Money	Director	XExercise of In-Money	+306K sh	—	—	305,810
2014-07-29	IMMUNE DESIGN CORP.Series C Preferred StockC Conversion	Director	CConversion	−306K sh	—	—	0
2014-01-06	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+2,870 sh	—	—	2,870
2013-12-23	CymaBay Therapeutics, Inc.Stock Appreciation RightA Award	Director	AAward	+2,335 sh	—	—	2,335
2013-10-31	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,470 sh	—	—	6,470
2013-05-23	ChemoCentryx, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2012-06-22	ChemoCentryx, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2012-02-13	ChemoCentryx, Inc.C Conversion	Director	CConversion	+115K sh	—	—	114,910
2012-02-13	ChemoCentryx, Inc.C Conversion	Director	CConversion	+1.71M sh	—	—	1,825,922
2012-02-13	ChemoCentryx, Inc.C Conversion	Director	CConversion	+42.2K sh	—	—	1,868,088
2012-02-13	ChemoCentryx, Inc.Series B Preferred StockC Conversion	Director	CConversion	−201K sh	—	—	0
2012-02-13	ChemoCentryx, Inc.Series C Preferred StockC Conversion	Director	CConversion	−28.7K sh	—	—	0
2012-02-13	ChemoCentryx, Inc.Series B Preferred StockC Conversion	Director	CConversion	−2.99M sh	—	—	0
2012-02-13	ChemoCentryx, Inc.Series C Preferred StockC Conversion	Director	CConversion	−428K sh	—	—	0
2012-02-13	ChemoCentryx, Inc.Series B Preferred StockC Conversion	Director	CConversion	−73.8K sh	—	—	0
2012-02-13	ChemoCentryx, Inc.Series C Preferred StockC Conversion	Director	CConversion	−10.5K sh	—	—	0
2010-10-08	ZYMOGENETICS INCU Disposition from Tender	Director	UDisposition from Tender	−72K sh	$9.75	−$702K	0
2010-08-17	ZYMOGENETICS INCM Exercise/Conversion	Director	MExercise/Conversion	+72K sh	$2.78	+$200K	72,000
2010-08-17	ZYMOGENETICS INCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−72K sh	—	—	0
2010-06-17	ZYMOGENETICS INCStock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2010-04-05	CORTCORCEPT THERAPEUTICS INCM Exercise/Conversion	10% Owner	MExercise/Conversion	+26.3K sh	$2.23	+$58.5K	26,250
2010-04-05	CORTCORCEPT THERAPEUTICS INCM Exercise/Conversion	10% Owner	MExercise/Conversion	+15K sh	$0.96	+$14.4K	41,250
2010-04-05	CORTCORCEPT THERAPEUTICS INCM Exercise/Conversion	10% Owner	MExercise/Conversion	0 sh	—	—	5,484,063
2010-04-05	CORTCORCEPT THERAPEUTICS INCM Exercise/Conversion	10% Owner	MExercise/Conversion	0 sh	—	—	180,204
2010-04-05	CORTCORCEPT THERAPEUTICS INC · Common Stock OptionM Exercise/Conversion	10% Owner	MExercise/Conversion	−26.3K sh	—	—	0
2010-04-05	CORTCORCEPT THERAPEUTICS INC · Common Stock OptionM Exercise/Conversion	10% Owner	MExercise/Conversion	−15K sh	—	—	0
2009-10-16	CORTCORCEPT THERAPEUTICS INCP Purchase	10% Owner	PPurchase	+337K sh	$1.38	+$465K	5,484,063
2009-10-16	CORTCORCEPT THERAPEUTICS INCP Purchase	10% Owner	PPurchase	+12.4K sh	$1.38	+$17.1K	180,204
2009-10-16	CORTCORCEPT THERAPEUTICS INC · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+118K sh	$0.13	+$14.8K	640,996
2009-10-16	CORTCORCEPT THERAPEUTICS INC · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+4,342 sh	$0.13	+$542.75	10,949

Recent filings

Accepted (ET)
Apr 44
PENHOET EDWARD0001209191-19-023681
SEC(opens sec.gov)
Jan 74
PENHOET EDWARD0001209191-19-002656
SEC(opens sec.gov)
Jan 64
Immune Design Corp.0001209191-17-002802
SEC(opens sec.gov)
Jan 64
Immune Design Corp.0001123292-16-001525
SEC(opens sec.gov)
Jun 54
SCYNEXIS INC0001178253-15-000063
SEC(opens sec.gov)
Jan 94
Immune Design Corp.0001123292-15-000123
SEC(opens sec.gov)
Jan 84
CymaBay Therapeutics, Inc.0001179110-15-000714
SEC(opens sec.gov)
Jul 314
Immune Design Corp.0001123292-14-000782
SEC(opens sec.gov)

Companies

Address

ONE EMBARCADERO CENTER SUITE 3700

SAN FRANCISCO, CA, 94111